Impact of Lentiviral Vector-Mediated Transduction on the Tightness
of a Polarized Model of Airway Epithelium and Effect of Cationic Polymer Polyethylenimine by Castellani, Stefano et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 103976, 11 pages
doi:10.1155/2010/103976
Research Article
Impact of Lentiviral Vector-Mediated Transduction on
theTightness ofaPolarizedModelof AirwayEpitheliumand
Effectof Cationic PolymerPolyethylenimine
Stefano Castellani,SanteDi Gioia,Teresa Trotta, Angela Bruna Mafﬁone,
andMassimo Conese
Department of Biomedical Sciences, University of Foggia, 71122 Foggia, Italy
Correspondence should be addressed to Massimo Conese, m.conese@unifg.it
Received 24 December 2009; Revised 31 March 2010; Accepted 9 May 2010
Academic Editor: Karl Chai
Copyright © 2010 Stefano Castellani et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Lentiviral (LV) vectors are promising agents for eﬃcient and long-lasting gene transfer into the lung and for gene therapy of
genetically determined pulmonary diseases, such as cystic ﬁbrosis, however, they have not been evaluated for cytotoxicity and
impact on the tightness of the airway epithelium. In this study, we evaluated the transduction eﬃciency of a last-generation
LV vector bearing Green Fluorescent Protein (GFP) gene as well as cytotoxicity and tight junction (TJ) integrity in a polarized
model of airway epithelial cells. High multiplicities of infection (MOI) showed to be cytotoxic, as assessed by increase in
propidium iodide staining and decrease in cell viability, and harmful for the epithelial tightness, as demonstrated by the decrease
of transepithelial resistance (TER) and delocalization of occludin from the TJs. To increase LV eﬃciency at low LV:cell ratio,
we employed noncovalent association with the polycation branched 25kDa polyethylenimine (PEI). Transduction of cells with
PEI/LV particles resulted in 2.5–3.6-fold increase of percentage of GFP-positive cells only at the highest PEI:LV ratios (1 ×107 PEI
molecules/transducing units with 50MOI LV) as compared to plain LV. At this dose PEI/LV transduction resulted in 6.5 ± 2.4%
of propidium iodide-positive cells. On the other hand, PEI/LV particles did not determine any alteration of TER and occludin
localization. We conclude that PEI may be useful for improving the eﬃciency of gene transfer mediated by LV vectors in airway
epithelial cells, in the absence of high acute cytotoxicity and alteration in epithelial tightness.
1.Introduction
Lentiviral (LV) vectors, such as those derived from HIV-
1, show exceptional promise as gene transfer agents and
have been proven to be eﬀective vehicles for transduc-
tion of epithelial cells of various organs, including airway
epithelial cells in the lung [1]. The epithelium lining the
bronchi/bronchioli is the target cell compartment for a
therapeuticapproachbasedongenedeliveryincysticﬁbrosis
(CF),achronicautosomalrecessivedisorderduetomutation
in the CF Transmembrane Conductance Regulator (CFTR)
gene [2]. LV vectors bear some fundamental characteristics
which could be useful for treating the CF lung disease, such
as: (1) they integrate into the host genome and determine
a long-term expression of either marker or CFTR gene in
animal and human xenograft models [3–7]; (2) they can be
repeatedly administered without loss of eﬃciency [8]; and
(3) they do not elicit a gross inﬂammatory response in vitro
[9] and in vivo [4, 10].
The mechanism(s) of viral vector interaction with the
apical plasma membrane and internalization has been an
intensely studied question, in particular for adenoviral and
adeno-associated viral vectors [11–16]. The expression of
receptors for these viral vectors and oncoretroviruses is
more abundant on the basolateral membrane than on
the apical side of the respiratory epithelium and they are
hardly accessible because of the airway tight junctions
[12, 17, 18]. HIV-1-derived LV vectors expressing vesicular
stomatitis virus G glycoprotein (VSV-G) on their capsid
have been shown previously to transduce a polarized airway2 Journal of Biomedicine and Biotechnology
epithelium only in the presence of preconditioning agents
with disruptive, although transient, eﬀects on tight junctions
[4, 5, 19]. These studies indicated entry block due to
absence or low numbers of VSV-G receptors on the apical
membrane of the airway epithelium, as it has been identiﬁed
for other viral vectors, or postentry block, concerning the
endocytosis route and nuclear import of viral genomes.
LV vectors have not been investigated in so much detail
in respect to their attachment to and internalization by
the cells. Building on the previoulsy published work by
Guibinga et al. [20], we observed that glycosaminoglycans
(GAGs) are involved in LV vector-mediated transduction of
polarized airway epithelial cells [21]. In that study, a good
transduction eﬃciency of polarized cellular monostrates
with a last-generation LV vector pseudotyped with VSV-G
was obtained, but only at high virus to cell ratios. Given that
no studies have tested directly the eﬀect of LV vectors on
the tight junction (TJ) stability and organization in airway
epithelial cells, we evaluated the transduction eﬃciency as
well as acute cytotoxicity, transepithelial resistance (TER),
and occludin localization at the TJ level in a bronchial-
derived cell line grown in polarized fashion. We ﬁnd that
the VSV-G-pseudotyped LV vector infection at high viral
loads is cytotoxic and determines occludin loss from the
apical plasmamembrane and reduction of TER. In order
to rule out the toxic eﬀect of LV particles, we used LV
virions noncovalently complexed with a cationic vector (i.e.
polyethylenimine).
2.MaterialsandMethods
2.1. Lentiviral Vector Production. The VSV-G pseudotyped
LV vector stock was prepared as previously described
[21, 22]. Brieﬂy, the lentivirus-based gene delivery system
comprises four components: (1) the packaging plasmid
pMDLg/pRRE, which contains elements such as structural
proteins and enzymes involved in the formation of the viral
particles, derived from the gag-pol genes; (2) the pRSV-
REV plasmid, which contains posttranscriptional regula-
tor for gag and pol expression, as well as nuclear RNA
export encoded by the rev gene; (3) the transfer vector
pRRLsin18.cPPT.CMV.eGFP.Wpre carrying the transgene
GFP with the insertion of the PPT and the woodchuck
post-transcriptionalregulatoryelement(WPRE);and(4)the
pMD2.G plasmid containing the heterologous glycoprotein
VSV-G. Cotransfection of the four plasmid vectors was
performedon293T cellsbycalciumphosphateprecipitation.
ThesupernatantcontainingLVparticleswasconcentratedby
two rounds of ultracentrifugation and assayed for p24 Gag
antigen by enzyme-linked immunosorbent assay. The viral
titer was determined by HeLa cell infection and subsequent
ﬂow cytometry analysis. The yield of the concentrated virus
was typically 109 transducing units (TU)/ml and the speciﬁc
activity ranged between 1.56 and 4.17 × 105 TU/ng of p24.
2.2. Polarization of Bronchial Epithelial Cells. 16HBE41o-
cells, derived from human bronchial epithelium (a kind gift
of Professor D. Gruenert, University of California at San
Francisco, CA, USA), were grown in MEM supplemented
with Earle’s salt, 10% fetal bovine serum, L-glutamine
and penicillin/streptomycin. They were routinely grown on
plastic ﬂasks coated with an extracellular matrix containing
ﬁbronectin/vitrogen/bovine serum albumin. The extracellu-
lar matrix coating is prepared in the laboratory as follows:
10μg/ml Fibronectin (BD Biosciences, CA, USA), 100μg/ml
albumin from bovine serum (Sigma-Aldrich, Milan, Italy),
and 30μg/ml bovine collagen type I (BD Biosciences) are
dissolved in MEM. The mixture is sterilized by 0.2μm
ﬁlter. To induce polarization, cells were seeded on 6.5-mm
diameter Snapwell, 0.4-μm pore size (Corning, Acton, MA,
USA) at 1 × 105 per ﬁlter coated with the same extracellular
matrix. Under these conditions, cells grow as a polarized
sheet of cells and develop a transepithelial resistance of 550
Ohm × cm2 on average, as measured by a voltohmmeter
(Millicell-ERS; Millipore, Vimodrone, Italy).
2.3. Transduction of Polarized Monolayers. Polarized cells
were incubated with the LV-GFP vector at diﬀerent multi-
plicities of infection (MOI) for 4 or 24 hours and then either
immediately studied for propidium iodide staining and cell
viability or incubated for further 48 hours for evaluation of
GFP expression. MOI refers to the number of TU per one
cell. Because we seeded 1 × 105 cells per well, a MOI of 10 is
equivalent to 106 TU; and a MOI of 100 refers to 107 TU, and
so forth.
Branched polyethylenimine (MW 25,000 Da) was
obtained from Sigma as 50% w/v solution. The solution was
titrated with HCl solution to a pH of 7.4 and used as a
4.5 mg/ml stock solution (100mM; stoichiometrically, this
solution corresponds to 10.8 × 1013 molecules of PEI per μl
of solution). Ten μl of saline containing diﬀerent amounts of
PEIstocksolutionwereaddedto10μlofsalinecontaining50
MOI(5×106 TU)ofL VinordertoobtainPEImolecules/TU
ratios ranging from 5 × 104 to 1 × 107(corresponding
to a range of 0.0625–12.5μg/μl as ﬁnal concentration of
PEI). Spermidine (Sigma-Aldrich) stock solution (1M) was
diluted in order to obtain a ﬁnal concentration rang-
ing from 0.08μM to 8mM (corresponding to spermidine
molecules/TU ratios ranging from 1 × 106 to 1 × 1011).
The suspension containing either PEI/LV or spermidine/LV
was incubated for 15 minutes at room temperature and then
added to cells. In another experimental setting, cells were
preincubated with spermidine (ﬁnal concentration ranging
from 0.08mM to 8mM) for 1.5 hours, washed, and then
infected with PEI/LV at the ratio of 1 × 107 with 50MOI
LV. The medium was changed 24 hours later and after
further 48 hours, a preliminary evaluation of GFP expression
was carried out by epiﬂuorescence and confocal microscopy
(see below). Analysis of GFP production by ﬂow cytometry
was performed as follows. The cells were washed twice
with phosphate-buﬀeredsaline (PBS),harvested bydigesting
with trypsin/ethylenediaminetetracetic acid (EDTA), and
ﬁxed in 2% paraformaldehyde. The cells were analyzed by
ﬂuorescence-activated cell sorting (FACS) with a EPICS
XL MCL ﬂow cytometer (Beckman Coulter Fullerton, CA,
USA). The percentage of GFP-positive cells was determined
after setting the gating on 99% of an untransfected controlJournal of Biomedicine and Biotechnology 3
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Figure 1: Eﬃciency and cytotoxicity of LV transduction. Polarized 16HBE41o- cells were incubated with diﬀerent MOIs for 24 (a, b, and c)
or 4 (d, e, and f) hours and then analyzed either immediately for membrane permeability (b and e) and viability (c and f) or incubated for
further 48 hours and evaluated for GFP expression (a and d). Percentage of propidium iodide (PI)-positive cells incubated with medium
only was 3.45 ± 0.28% and subtracted from the other values. In the viability assay, untreated cells were incubated with medium only and
considered as 100%. Data are expressed as means ± SD of two-three experiments. A and B: ∗P<. 05 for 500 and 2000 MOIs versus 50 and
1 0 0M O I s .Ca n dF :∗P<. 05 for 500 and 2000 MOIs versus mock.
population of cells and by subtracting the ﬂuorescence of
the untransfected control cells. Ten thousand cells were
examined in each experiment. Analysis of GFP production
was performed by plotting the FLH-1 channel (512–537nm,
with peak at 525nm) against the FLH-3 channel (608–
632nm, with peak at 620nm).
2.4. Propidium Iodide Staining. Propidium iodide is an eﬀec-
tive stain to identify nonviable cells since the dye is excluded
by intact cell membranes and passes through damaged cell
membranes and intercalates with DNA and RNA to form
ab r i g h tr e dﬂ u o r e s c e n tc o m p l e x[ 23, 24]. Brieﬂy, cells on
transwells were incubated with 25μg/ml propidium iodide
(Sigma-Aldrich) for 20 minutes on ice, were washed with
PBS, harvested by digesting with trypsin/EDTA, and resus-
pendedinPBS.Ineachexperiment,asatoxicitycontrol,cells
were incubated with 0.1% Triton X-100 (Sigma-Aldrich)
for 5 minutes at room temperature. This treatment resulted
in 44% of propidium iodide-positive cells on average.
After various treatments, cells were analysed by FACS. The
percentageofpropidiumiodidepositivecellswasdetermined
after setting the gating on 99% of an untreated control
population of cells and by subtracting the ﬂuorescence of
untreated control cells. Ten thousand cells were examined4 Journal of Biomedicine and Biotechnology
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Figure 2: Eﬀe c to fL Vt r a n s d u c t i o no nT E R . Polarized 16HBE41o-
cells were incubated with diﬀe r e n tM O I sa n d ,4o r2 4h o u r sl a t e r ,
TER was measured. Mock is represented by cells incubated with
medium only. As a positive control, cells were incubated with
12mM EGTA for 30 minutes. TER values are shown as % of mock
cells that were 523 ± 44 Ohm × cm2. Data are expressed as means
± SD of three experiments. A: ∗P<. 05 for EGTA versus mock. B:
∗P<. 05 for EGTA, 100, 500, and 2000 MOIs versus mock.
in each experiment. Analysis of propidium iodide positive
cellswasperformedbyplottingtheredchannel(FLH-2;562–
588nm, with peak at 575nm) against the FLH-1 channel.
2.5. MTT Assay. MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl tetrazolium bromide) is a water-soluble yellow dye
that is readily taken up by viable cells and reduced by
the action of mitochondrial dehydrogenases. The reduction
product is a water-insoluble blue formazan, that must
then be dissolved for colorimetric measurement. Brieﬂy,
a stock solution of MTT (Sigma-Aldrich) in phosphate
buﬀered saline (PBS) (5mg/ml) was added to the upper
compartment of each well reaching a ﬁnal concentration of
0.5mg/ml (in 200μlo fc o m p l e t em e d i u m ) .A f t e r4h o u r s
the formazan crystals were dissolved in a 10% SDS/50%
dimethyl-formamide solution, and 100μl of the solution
weretransferredina96-wellplateandmeasuredspectropho-
tometrically by an ELISA reader (PowerWave HT, Bio-tek,
Milan, Italy) at a wavelenght of 570nm with a reference
wavelenght of 690nm. The relative viability was calculated
in respect to untreated cells (considered as 100%).
2.6. RT-PCR. Peripheral blood mononuclear cells (PBMCs)
were isolated from the whole blood of three normal donors
using Lymphoprep (Axis-Shield, Oslo, Norway), according
to the published protocol [25], and pooled. Total RNA
was extracted from polarized 16HBE14o- cells and PBMCs
using Trizol reagent (Invitrogen, S. Giuliano Milanese, Italy)
following the protocol suggested by the manufacturer. The
concentration of RNA was estimated by Nanodrop 1000
spectrophotometer (Thermo Scientiﬁc, Waltham, MA, USA)
at 260nm wavelength and the purity was conﬁrmed by
measuring the absorbance ratio at 260/280nm wavelengths.
1μg RNA was used to prepare cDNA by using a RevertAid
First Strand cDNA Synthesis Kit (Fermentas, Burlington,
Canada). Retrotranscription was performed under the fol-
lowing conditions: incubation for 60 minutes at 37◦C
followed by 5 minutes at 70◦C. RNA were retrotranscripted
in the presence of 200 units of RevertAid M-MuLV Reverse
Transcriptase, 0.4μMo fo l i g o( d T ) 18 primer, 1 mM of
nucleotide mix, 20 units of Ribolock Rnase Inhibitor, and
commercialbuﬀer(Fermentas).ForthePCRreaction,100ng
of cDNA were ampliﬁed in the presence of 1 unit Taq
polymerase (Fermentas), 0.4μMo fe a c hp r i m e r( E u r o ﬁ n s
MWG Operon/M Medical Srl, Milan, Italy), 0.2mM of
nucleotide mix, and commercial buﬀer containing 2mM
MgCl2 (Fermentas). The primers for occludin ampliﬁca-
tion were forward 5’-AGTGAGTGCTATCCTGGGCAT- 3’
and reverse 5’-CCTTTGCAGGTGCTCTTTTTG-3’ which
produced a DNA segment of 600bp. PCR was performed
under the following conditions: initial denaturation for 2
minutes at 94◦C, followed by 25 cycles of denaturation
(15 seconds, 94◦C), annealing (30 seconds, 58◦C) and
extension (1 minute, 72◦C). As control for RNA integrity,
we performed the β−actin PCR reaction using the fol-
lowing primers: forward 5’-CAACTGGGACGACATGGA-
3’ and reverse 5’-ACGTCACACTTCATGATGGA-3’, which
produced a DNA segment of 610 bp. PCR was performed
under the following conditions: initial denaturation for 2
minutes at 94◦C, followed by 35 cycles of denaturation (15
seconds, 94◦C), annealing (30 seconds, 56◦C) and extension
(1 minute, 72◦C). The identity of ampliﬁed products was
conﬁrmed by determination of molecular size on agarose gel
electrophoresis (1.5% agarose in buﬀer containing 40mM
Tris/acetate and 1mM EDTA) and visualized by ethidium
bromide staining (0.5μg/ml) under ultraviolet light.
2.7. Confocal Microscopy. For occludin immunolocalization,
polarized 16HBE14o- cells were washed three times with
PBS, ﬁxed in 3% paraformaldehyde, 2% sucrose, and perme-
abilized with ice cold Triton Hepes buﬀer (20mM HEPES,
300mM sucrose, 50mM NaCl, 3mM MgCl2,0 . 5 %T r i t o n
X-100, pH 7.4) for 5 minutes at room temperature. Cells
were incubated with blocking solution (2% bovine serum
albumin [BSA], 2% FBS) for 15 minutes at 37 ◦C, then with
ﬂuorescein isothiocyanate (FITC)-conjugated mouse anti-
Occludin antibody (Zymed Laboratories Inc., San Francisco,
CA, USA) (dilution 1 : 100) for 30 minutes at 37 ◦C. Cells
were rinsed three times with 0.2% BSA. Filters were excised
a n dp l a c e ds i d eu po nag l a s ss l i d e ,a n do v e r l a y e dw i t ha
drop of Fluorescent Mounting Medium (Dako, Milan, Italy)
followed by a coverslip. Cells were analyzed using Nikon
TE2000 microscope coupled to a Radiance 2100 confocal
dual-laser scanning microscopy system (Bio-Rad, Segrate,Journal of Biomedicine and Biotechnology 5
12 345
OCLN λ ACT
(a)
10μm
(b)
10μm
(c)
10μm
(d)
10μm
(e)
10μm
(f)
Figure 3: Eﬀect of LV transduction on occludin localization. Expression of occludin mRNA by RT-PCR (a). Note that occludin (OCLN)
transcript is detected in 16HBE14o- cells (lane 1) but not in PBMCs (lane 2). β-actin (ACT) transcripts were detected in 16HBE14o- and
PMBCs (lanes 4 and 5, respectively). In lane 3, λHindIII marker. Polarized 16HBE41o- cells were incubated with 50 (C), 500 (D) or 2000 (E)
MOIs and, 24 hours later, occludin localization was evaluated by immunoﬂuorescence and confocal microscopy. Controls included mock
cells (B) and cells treated with 12 mM EGTA for 30 minutes (F). En-face micrographs are shown. Occludin-speciﬁc signal is in green. A
peripheral chicken-wire pattern of occludin localization is noted in B and C. In D and E, white arrows point out to lack of occludin staining
at cell borders and between cells. In F, occludin staining is lost from cell borders and distributed intracellularly. Note that some intracellular
s i g n a li sv i s i b l ea l s oi nB - E .B a r :1 0μm.
Italy). Specimens were viewed through a 60X oil immersion
objective. The microscope was equipped with a FITC ﬁlter
(excitation 395nm, emission 509nm). Digital images were
processed using the program Laser Sharp 2000 (Bio-Rad).
For GFP detection, cells were ﬁxed and permeabilized,
incubated with propidium iodide (diluted at 1 : 5,000 of
1mg/ml stock solution) for 5 minutes at 37◦C, and washed.
Filters were mounted and observed through the FITC and
TRITC (excitation 488nm, emission 620nm) ﬁlters.
2.8. Statistics. Results are presented as means ± standard
deviation (SD) of the means. Statistical signiﬁcance of
diﬀerences was evaluated by a two-tailed unpaired Student’s
t-test.
3. Results
3.1. Transduction Eﬃciency and Cytotoxicity of LV Particles.
We have previously demonstrated LV-mediated transgene
delivery and expression in polarized airway epithelial cells
at high LV: cell ratios, necessitating at least 2000 MOI
(Multiplicity of Infection) [21]. High MOIs could be
toxic to the cells. Thus, we interrogated the transduction
eﬃciency and the cytotoxicity of LV vectors in polarized
16HBE41o- cells. Cells were incubated with diﬀerent MOIs
of LV particles for 24 hours, and then either immediately
studied for propidium iodide staining (to assess membrane
permeability) and viability (by means of the MTT assay),
o ri n c u b a t e df o rf u r t h e r4 8h o u r sf o re v a l u a t i o no fG F P
expression. As shown in Figure 1(a), the higher the MOI the
higher the percentage of GFP-positive cells. Only cells with
alteredplasmamembranepermeabilitywillintakepropidium
iodide which will bind nuclear DNA. The higher the MOI
the higher the percentage of propidium iodide-stained cells
(Figure 1(b)). The viability was decreased only at MOIs 500
and 2000 (Figure 1(c)).
To investigate acute cytotoxicity of LV particles, mem-
brane permeability and viability were assayed also after
incubation of cells with LV particles for 4 hours. At any MOI,
LV particles did not exert any direct permeabilizing eﬀect
on polarized cells (Figure 1(e)) and decreased the viability6 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬃciency and eﬀect on membrane permeability of PEI/LV vectors. Polarized 16HBE41o- cells were incubated with LV (50 MOI)
either alone, formulated at diﬀerent PEI molecules/TU ratios (A), or at diﬀerent spermidine molecules/TU ratios (B) for 24 hours and then
further incubated for 48 hours and evaluated for GFP expression. In another experimental setting, cells were pre-incubated with spermidine
(range 0.08–8mM) prior to addition of PEI/LV vector formulated at 1 × 107 ratio with 50 MOI LV (C). Note that PEI/LV increased the
transduction eﬃciency by 3.6 fold as compared to plain LV. Data are expressed as means ± SD of two-three experiments. A: ∗P<. 05 for 107
PEI/LV TU versus all the other conditions except 5 × 106.C :∗P<. 05 for all the conditions versus LV alone.
30μm
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Figure 5: GFP detection by confocal microscopy. Polarized 16HBE41o- cells were incubated with 50 MOI LV (a) or with PEI/LV formulated at
1 ×107 ratiowith50MOILV(b).72hourslatercellswerestainedwithpropidiumiodideandanalyzedbyconfocalmicroscopy.GFP-positive
cells are in bright green while nuclei are stained in red. Note an approximately 3-fold increase in GFP-positive cells in B as compared to A.
En-face micrographs are shown. Bar: 30μm.
only at MOI 2000 (Figure 1(f)). Under these conditions, the
percentage of transduced cells was lower than in the 24-hour
protocol (Figure 1(d)).
These data show a dose-dependent cytotoxic eﬀect of
the LV vector, in terms of both alteration of membrane
permeability and cell viability.
3.2. Eﬀect of LV Transduction on Transepithelial Resistance
and Occludin Localization. Since the LV vector shows a
disturbing eﬀect on membrane permeability, the impact
of LV particles on the tightness of the epithelial monos-
trates was initially investigated by measuring transepithelial
resistance (TER). TER was decreased in a MOI-dependentJournal of Biomedicine and Biotechnology 7
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Figure 6: Cytotoxicity of PEI/LV vectors. Polarized 16HBE41o- cells were incubated with LV (50 MOI) either alone or formulated at diﬀerent
PEI molecules/TU ratios with 50 MOI LV for 24 hours and then analyzed for propidium iodide staining (a) or MTT assay (b). The same
amounts of PEI used in the formation of PEI/LV vectors were tested for their cytotoxicity. Percentage of propidium iodide (PI)-positive cells
incubated with medium only was 4.68 ± 1.8 and subtracted from the other values. In the viability assay, untreated cells were incubated with
medium only and considered as 100%. Data are expressed as means ± SD of two-three experiments. a: ∗P<. 05 for 107 PEI/LV TU and free
PEI versus all the other conditions except 5 × 106.
fashion when cells were incubated with LV vectors for 24
hours (Figure 2(a)), whereas was not aﬀected at 4 hours
(Figure 2(b)). The eﬀect observed with 2000 MOI was sim-
ilar to that achieved by ethylene glycol-bis(2-aminoethyl)-
N,N,N
 ,N
 -tetra-aceticacid(EGTA)(Figure2),aCa2+ chela-
tor known to transiently disrupt epithelial tight junctions
[26].
Tight junctions (TJs) are multiprotein complexes com-
posed of integral proteins (claudins, occludin, and JAM
[junctionaladhesionmolecule])thatassociatewithcytoplas-
mic plaque proteins (ZO-1, ZO-2, and ZO-3). The former
mediate cell-cell adhesion, while the latter function as a
bridge between the TJ and the actin cytoskeleton [27, 28].
Since occludin has been shown to be internalized upon
infection with group B coxsackievirus (CVB) [29]a n d
hepatitis C virus (HCV) [30], we chose to study occludin
expression and localization in cells infected with the LV
vector.PreliminarlyweevaluatedmRNAoccludinexpression
in 16HBE41o- cells. Reverse transcription-PCR revealed the
presence of an occludin speciﬁc band (Figure 3(a)). Freshly
isolated and unstimulated lymphocytes and monocytes have
been shown to not express occludin at the mRNA and
protein level [31, 32]. PBMCs obtained from normal donors
were negative for occludin mRNA expression (Figure 3(a)),
conﬁrming the speciﬁcity of the occludin ampliﬁcation in
16HBE14o- cells.
Polarized 16HBE14o- cells were incubated with the LV
vector at diﬀerent MOIs and analyzed by immunoﬂuo-
rescence and confocal microscopy 24 hours postinfection.
Untreated cells displayed sharp circumferential organization
of occludin at the lateral membrane between neighbouring
cells (Figure 3(b)). In EGTA-treated cells, occludin was
chaotically distributed within the cytosol (Figure 3(f)). High
LV MOIs (500 and 2000) determined discontinuity in the
occludin pattern at TJ location (Figures 3(d) and 3(e),
with 2000 MOI causing stronger disorganization of TJs.
On the other hand, 50 MOI did not cause any alteration
in occludin localization at the cell periphery (Figure 3(c)).
Taken together, these results show that high—but not low—
viral-to-cell ratios determine disruption of TJs when TJs are
probed at 24 hours postinfection.
3.3. Eﬀect of PEI and Spermidine on LV-Mediated Trans-
duction. These results prompted us to investigate if LV-
mediated transduction at low MOI could be enhanced by
the polycation polyethylenimine (PEI). Cationic lipids and
polymers have been used to increase retrovirus titer and
to enhance transduction of target cells [33–36]. Various
amounts of branched 25kDa PEI molecules were mixed with
50 MOI of LV particles to obtain diﬀerent PEI molecules/TU
ratios. Cells were incubated with LV alone or PEI/LV for
24 hours and GFP expression was evaluated 48 hours later
by cytoﬂuorimetry. The percentage of transduced cells did
not change with low PEI:LV ratios as compared with LV
alone, and only the 107 ratio produced a signiﬁcant 2.5-
fold increase in GFP-positive cells as compared to plain
LV (Figure 4(a)). Epiﬂuorescence and confocal microscopy
analysis of transduced cells conﬁrmed that PEI increased
by approximatively 3 fold the eﬃciency of LV-mediated
transduction, as visualized by the number of GFP-positive
cells (Figure 5).
To see whether the enhancing eﬀect of PEI could be
universal to polyamines, we sought to determine the eﬀect of
native spermidine, a polyamine which is cationic at physio-
logical pH [37]. A wide range of spermidine molecules/TU
ratios was tested (corresponding to a molar concentration
range from 0.08μMt o8m M ) ,b u tn oe ﬀect on the trans-
duction rate given by plain LV particles (used at 50 MOI)
wasobserved(Figure4(b)).Thus,theenhancingeﬀectseems
to be unique to PEI. In alternative, we investigated whether
spermidine could inhibit the PEI/LV-mediated transduction.
In this case we used only the highest molar concentrations of
spemidine. Preincubation of polarized 16HBE14o- cells with
native spermidine (0.08–8mM) before addition of PEI/LV
formulated at the highest ratio (1 ×107 with 50 MOI LV)
did not exert any alteration in the eﬃciency of PEI/LV
(Figure 4(c)). In these experiments, the enhancing eﬀect of
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3.4. Cytotoxicity of PEI/LV. PEI/LV particles and free PEI
were interrogated for their cell toxicity using the propidium
iodide staining and the MTT assay. Cells were incubated
with vectors for 24 hours, stained with propidium iodide
for 30 minutes, and analyzed by cytoﬂuorimetry. As shown
in Figure 6(a), only cells incubated with the highest PEI:LV
ratios with 50 MOI LV, (107 PEI/TU) showed a signiﬁcant
increase in nuclei stained with propidium iodide (from 0%
up to 6.5 ± 2.4%). Intriguingly, the same amount of PEI
alone (1 × 107 molecules) caused the uptake of propidium
iodide by 9.9 ± 4.9% of cells. Figure 6(b) shows that
P E I / L Va n df r e eP E Ie x e r t e das m a l lt o x i ce ﬀect on cells
at highest doses. These results suggest that the membrane
permeabilizing eﬀect of PEI/LV vectors could be attributed
to free PEI, as previously shown by the toxicity exerted by
PEI alone [38].
3.5. Eﬀect of PEI/LV on TER and Occludin Localization.
TER was measured at 4 and 24 hours postinfection and
was not aﬀected by PEI/LV particles (not shown). Occludin
localization was not altered by incubation of cells with
PEI/LV at 24 hours (Figures 7(b)–7(d)). Also free PEI
(107 molecules) did not exert any eﬀect on TJ integrity
(Figure 7(e)).
4. Discussion
Positively charged polycations such as polybrene are known
to be required for eﬃcient infection of cells with retroviruses
and retrovirus vectors, possibly by stabilizing the interaction
between negatively charged virus particles and target cellular
membranes [20, 39]. Indeed, polybrene has been used also
in LV-mediated transduction of polarized epithelial cells
obtained from the airways [40]. In our hands, polybrene
was toxic to the cells and thus it was withdrawn from
the transduction protocol. For this reason, we had to use
high MOIs (i.e. at least 2000) to achieve a meaningful
transduction of polarized airway bronchial and tracheal
epithelial cells [21]. In this study, we show that high LV
MOIs are toxic to polarized airway epithelial cells, which are
considered a good approximative model for native airway
epithelium [26, 41–43]. High MOIs determined an increase
in membrane permeability at 24 hours but not at 4 hours,
suggestingthatthedirectinteractionofLVparticleswithcells
is not harmful, rather it is so for entry, transport, and viral
transcription within the cytosol. Interestingly, the damage
caused by LV particles was reﬂected also by the decrease of
TER and loss of occludin at the TJs between cells. The MTT
assay shows that only high LV doses decreased the cellular
viability both at 4 and 24 hours. However, this was a small
decrease as compared with the pemeabilizing eﬀect. These
results strongly suggest that LV particles exert their toxic
action through direct interaction with TJ proteins, an eﬀect
visible only at 24 hours. Some recently acquired data indicate
that proﬁcient viral infection is dependent on the interaction
ofviralenvelopeglycoproteinswithTJproteins.Theprimary
CVB receptor, the coxsackievirus and adenovirus receptor
(CAR), is a transmembrane component of the TJ [44]a n d
CVB enters polarized epithelial cells from the TJ, causing
a transient disruption of TJ integrity [45]. CVB does not
induce major reorganization of the TJ, but stimulates the
speciﬁc internalization of occludin within macropinosomes
[29]. HCV envelope glycoproteins induce a loss of claudin-
1, ZO-1, and occludin-delineated junctional accumulation
[30] and occludin is required for late entry step of HCV
into cells [46]. Overall, based on our previous publication
[21], we speculate that VSV-G-pseudotyped LV virions
are concentrated on the apical surface of polarized airway
epithelial cells by initial attachment to GAGs. The binding
of LV particles with GAGs is based on nonelectrostatic
interactions [20]. In a further step, LV virions should then
bind to entry receptors (not identiﬁed yet) and eventually to
occludin for internalization.
Loss of occludin from the TJs and their opening could
be a disadvantage in lung diseases such as CF, because of the
presence of bacteria and bacterial products in the airways.
In order to ﬁnd a transduction protocol with less viral
loads, minimal toxicity and eventually no delocalization of
occludin from the TJs, we have combined LV particles with
the polycation PEI, based on the rationale that a cationic
component would charge associate with LV particles, which
carry a net negative surface charge. Several previous studies
have reported the use of cationic molecules to enhance
viral uptake and subsequent transgene expression in vitro
and in vivo, mainly for adenoviral [47–52] and retroviral
vectors [33–36]. In particular, PEI facilitated transduction
eﬃciency by adenoviral vectors in cultured mouse myotubes
[47]andin9Lgliosarcomacells[49]andenhancedretroviral
transduction in NIH3T3 cells [36]. To our best knowledge,
ours is the ﬁrst study showing that PEI enhanced LV-
mediated transduction of airway epithelial cells. PEI/LV
particles increased membrane permeability only at the
highest PEI/LV ratio, an eﬀect likely due to excess free PEI
[53], with a little eﬀect on the viability. Indeed, PEI is known
to induce the formation of transient, nanoscale holes in the
membranes of living cells and these holes allow a greatly
enhanced exchange of materials across the cell membrane,
including propidium iodide [54]. Although we have not
investigatedthemembranepermeabilitywithspermidine/LV
vectors, the fact that spermidine had no enhancing eﬀect
on LV-mediated transduction supports the notion that the
PEI’sactionisduetoamembranedestabilizingeﬀect.PEI/LV
particles and free PEI did not cause any alteration on TER
and in occludin localization, indicating that PEI-induced
nanoscale holes in the plasma membrane do not aﬀect TJ
integrity.
In conclusion, PEI/LV vectors are more eﬃcient than
LV alone—used at low viral load—in transducing polar-
ized epithelial cells without so pronounced cytotoxicity,
and, more importantly, without disrupting tight junctions.
Because the transduction eﬃciency mediated by PEI/LV is
still low it needs further reﬁnement for obtaining higher
transduction rates of polarized airway epithelia, a goal
which could be achieved by testing other PEI architectures
[55]. For these reasons the PEI/LV vector warrants further
characterization for being considered as a valid tool in gene
therapy of genetic lung diseases.Journal of Biomedicine and Biotechnology 9
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Figure 7: Eﬀect of PEI/LV vectors and free PEI on occludin localization. Polarized 16HBE41o- cells were incubated with free 1 × 107 PEI
molecules (e) or PEI/LV vectors formulated at ratios of 5 × 104 (b), 1 × 106 (c), and 1 × 107 (d) with 50 MOI LV for 24 hours and then
evaluated for occludin localization by confocal microscopy. Mock (a) is represented by cells incubated with medium only. Note in green the
circumferential localization of occludin between cells, with some intracellular staining. En-face micrographs are shown. Bar: 10μm.
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